EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Recall Number: D-168-2013
Firm: Pacira Pharmaceuticals, Inc.
Classification: Class II
Status: Terminated
Report Date: 20130306
Initiation Date: 20121217
Termination Date: 20130503
Reason for Recall
Subpotent; bupivacaine
Product Description
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA